Pd34-11 nivolumab plus gemcitabine-cisplatin versus gemcitabine-cisplatin alone in patients with previously untreated unresectable or metastatic urothelial carcinoma: results of analyses to characterize benefit in responders from the phase 3 checkmate 901 trial

Journal of Urology(2024)

引用 0|浏览5
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要